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Abstract. 
Ameloblastomas are benign but locally invasive odontogenic epithelial tumors. They have a 
high tendency to recur, but a low incidence of metastasis. This is the first reported case presenting 
a perineural spread of metastasis in ameloblastoma. 
This is the case of a 74-year-old man with left mandibular granular cell type ameloblastoma 
diagnosed in 1978. Local recurrence occurred 26 years after tumor excision, and he again re-
ceived surgical treatment. Distant metastasis with intracranial perineural spread along the sixth 
cranial nerve occurred 9 years after the second operation. The diagnosis was confirmed by ex-
cisional biopsy of the intracranial lesion and a needle biopsy of the left mandibular tumor. 
Only 5 patients have been previously reported with metastasized granular cell type amelo-
blastoma. We herein have presented a characterization of granular cell type ameloblastomas and 
a possible mechanism for perineural spread. 
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中文摘要 
背景：造釉細胞瘤為一種具局部侵犯性的牙源性上皮良性腫瘤。有高復發率的傾向，少
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數可能會有轉移的情況。本例為第一個轉移性造釉細胞瘤以神經周圍擴散來表現之案例
報告。 
病例報告：病患為一 74 歲的男性，於 35 年前診斷左下頷骨顆粒造釉細胞瘤。26 年後，
在手術部位發現局部腫瘤復發，故接受第二次手術切除。局部復發及顱內轉移性病變併
外旋神經周圍擴散在第二次術後 9 年發生，經由原發部位及顱內腫瘤切片結果確診。 
討論：轉移性顆粒造釉細胞瘤在文獻上僅有五例，本文著重在討論顆粒造釉細胞瘤的特
色及其神經周圍擴散轉移的可能致病機轉。 
 
關鍵字: 造釉細胞瘤、顆粒細胞、轉移、神經周邊擴散、外旋神經 
 
INTRODUCTION 
Ameloblastomas (also previously known as ada-
mantinomas) are slow-growing, locally invasive be-
nign epithelial odontogenic tumors located in the 
mandible. These tumors usually occur during the fourth 
decade of life [1], and have a high recurrence rate (50 - 
72%) after excision [2], but rarely progress to malig-
nancy or demonstrate metastasis [3]. Clinically, ame-
loblastomas are separated into 3 subtypes: solid (or 
multicystic), mural (or unicystic), and peripheral type. 
Malignant changes in ameloblastomas have been clas-
sified into 2 different types of lesions: malignant (me-
tastasizing) ameloblastoma, and ameloblastic carci-
noma, according to the 2005 WHO classification. 
Metastasizing ameloblastoma is considered when the 
metastatic lesion and primary site tumor showed 
comparable benign histological picture. Ameloblastic 
carcinoma is diagnosed if cytological characteristics of 
malignancy are noted within the architectural features 
of ameloblastoma. 
Based on a review of relevant literature, this is the 
first report of a case of intracranial perineural tumor 
spread of ameloblastoma.  
 
 
CASE REPORT 
A 74-year-old man with hypertension, chronic 
hepatitis B, and bilateral cataracts reported that he 
underwent a segmental mandibulectomy of his left 
mandible to excise a tumor 35 years earlier. At that 
time, a histological examination showed the presence 
of ameloblastoma. Local recurrence of the left mandi-
ble tumor occurred 26 years later, when the tumor was 
again excised. Any extent of resection margin was not 
available in the first operation but the resection margin 
in the second operation was free from tumor involve-
ment. The patient received regular follow-up care after 
the second operation without adjuvant chemotherapy 
or radiotherapy. A final head and neck MRI was per-
formed 4 years ago, and an image report indicated no 
evidence of tumor recurrence, but the recurrence may 
have been obscured by a significant prosthetic artifact. 
The patient did not receive a follow-up exam after the 
MRI study. 
At his most recent visit, the patient complained of 
progressive, insidious onset of blurred vision, which 
had been occurring for one year. Numbness of the left 
mandibular area had been stationary after the opera-
tion, and no retrobulbar pain, swelling, or erythema-
tous change of the left eye or exophthalmos was noted. 
The patient visited a local hospital for first aid, and left 
sixth cranial nerve palsy related diplopia was diag-
nosed at that time; he was then referred to our hospital 
for further workup. We conducted a physical exami-
nation which showed mild erythematous and swelling 
of the left mandibular area, with one 1.5 x 1.5 cm2 
indurated mass. No intra-oral lesion could be detected  
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Figure 1. Brain MRI and head & neck CT. (A) Axial T2 weighted image and (B) axial post-contrast TOF (time of 
flight) source image showing left cavernous sinus and Meckel’s cave lesion (open arrow) with extension 
along left sixth cranial nerve and enlarged Dorello’s canal (closed arrow). (C) Coronal T1 weighted 
image revealing intact skull base. (D) Axial view of head & neck CT with contrast revealing left man-
dibular tumor (asterisk) with heterogeneous solid and cystic component 
 
 
by palpation. Neurological examination revealed clear 
consciousness, with complete left abducens nerve 
palsy and mild hypoesthesia over the left mandibular 
area. The other cranial nerves functioned normally, and  
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Figure 2. Intra-operative photography. (A) Intra-operative photo shows bulging of the Gasserian’s ganglion 
(asterisk) with tumor below the ganglion. Three branches of the trigeminal nerve (V1-V3) and the 
greater superficial petrosal nerve (GSPN, closed arrow) were preserved. (B) Normal nerve fibers were 
encountered after excisional biopsy (opened arrow) 
 
 
no limb weakness, sensory changes, or cerebellar signs 
were detected. Magnetic resonance imaging of the 
cranium revealed one 1.2 cm lesion within the left 
Meckel’s cave, which extended into the posterior fossa 
along the course of the left abducens nerve. The skull 
base was intact, and without evidence of local invasion 
(Figure 1). The left Dolenc’s approach was used for 
excisional biopsy. The left Gasserian ganglion was 
pushed laterally by the tumor. We opened the left 
Gasserian ganglion along the course of nerve fiber, and 
a single 0.8 x 1 x 1.2 cm3, pink tan, elastic, normal 
vascularized tumor was encountered, which was tightly 
attached to the adjacent nerve fibers. The prepontine 
cistern was opened during tumor excision (Figure 2). 
After the operation, left abducens nerve palsy remained, 
and partial left oculomotor and trochlear nerve palsy 
were also noted. The patient otherwise recovered well 
from the surgery. 
Histological examination showed monomorphic 
cells with round nuclei, fine chromatin, indistinct cell 
borders, and abundant granular eosinophilic cytoplasm 
arranged in a solid growth pattern and focal (pseudo) 
papillary configuration. No mitotic activity or tumor 
necrosis was seen. Some Schwann cell-like spindle 
cells which tested positive with S100 stain were also 
seen. Immunohistochemical studies showed that the 
eosinophilic granular cells had a very low mitotic index, 
as revealed by < 1% Ki67 labeling. These cells were 
strongly positive for cytokeratin (AE1/AE3), CD68, 
NSE, PAS, and dPAS. They were moderate-to-weakly 
positive for EMA, equivocally focal positive for syn-
aptophysin and S100, and stained negative for GFAP, 
vimentin, TTF-1, Hepar1, CK7, and p53 (Figure 3). 
We attempted to retrieve the prior histopathology re-
sults which led to an inconclusive diagnosis, but they 
were not available. 
Meanwhile, a head and neck contrast CT was 
conducted to examine for a suspected recurrence of left 
mandibular ameloblastoma. The CT scan revealed a 
5.5 cm lobulated mass showing heterogeneous solid 
and cystic components, with bony destruction at the 
left mandible (body to ramus) (Figure 1). No abnor-
mally enlarged neck lymph nodes were noted. A 
CT-guided biopsy was performed for proof of malig-
nant ameloblastoma after the cranial surgery. The his-
tological exam revealed tumor islands showing pe-
ripheral palisading and centrally having abundant eo-
sinophilic granular cytoplasm, with focal cystic changes  
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Figure 3. Histological examination of Meckel’s cave lesion. (A) H&E stain, 200x, showing monomorphic cell 
with abundant granular eosinophilic cytoplasm arranged in solid growth pattern. (B) The Ki67 labeling, 
200x, shows a low mitotic index (<1%). The tumor is strongly positive for (C) cytokeratin, 400x, (D) 
NSE, 400x, and (E) dPAS, 400x. (F) The S-100 stain, 200x, is moderate-to-weakly positive, and the (G) 
GFAP, 200x, stain is negative. (H) H&E stain, 200x, needle biopsy of left mandibular tumor shows 
tumor islands with peripheral palisading and centrally having abundant eosinophilic granular cytoplasm 
as a pathological result of Meckel’s cave lesion 
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(Figure 3). The picture was similar to the left Meckel’s 
lesion and compatible with a diagnosis of metastasiz-
ing ameloblastoma.  
Thereafter, metastasizing granular cell type ame-
loblastoma with intracranial perineural spread was 
diagnosed according to the above findings. The patient 
was discharged uneventfully, and received follow-up 
in the oral surgery clinic for surgical management of 
local recurrence. 
 
DISCUSSION 
Ameloblastomas are benign, slow-growing tumors, 
with unknown mechanisms of metastasis. The inci-
dence of metastasis for ameloblastoma was earlier 
reported as 2%, and metastasis is believed to be closely 
linked to the number of local recurrences, and timing of 
surgeries [5]. The above factors may stimulate malig-
nant behavior, and result in hematogenous seeding via 
lymph or blood vessels during an operation [1]. 
According to a review of the literature, amelo-
blastoma mainly metastasizes to the lungs (78% - 
83.6%) [6]. Other metastatic sites include the cervical 
lymph nodes, cervical/thoracic vertebrae, the brain, 
liver, kidneys, and the intestines [7]. The average in-
terval between diagnosis of the primary tumor and 
diagnosis of metastasis is 14 to 18 years (range, 2 
months to 45 years) [5,6]. After metastasis, the 5-year 
survival rate is 44%, and the average survival duration 
is 6.7 years [5]. 
 
Granular Cell Ameloblastoma 
Various microscopic patterns of ameloblastoma 
have been defined (follicular, plexiform, acanthomat-
ous, granular cell type, vascular, desmoplastic, papil-
liferous-keratotic, and dentin ameloblastoma). Granu-
lar cell variants are only observed in 3.5% of amelo-
blastoma cases [8]. Regarding the immunohistochem-
ical (IHC) characterization of granular cell ameloblas-
toma, the pattern is unusual and inconsistent [9]. The 
result of IHC study from the literature includes positive 
results for S-100 and CD68 (related to lysosomal gly-
coprotein) staining. Positive staining results for vimentin, 
β-catenin, lysozyme, α-1-antichymotrypsin, and a vari-
ety of lectins have also been reported [9,10]. The above 
findings also suggest that altered tumor function may 
be related to cell aging. The cellular aging hypothesis 
was also supported by negative Bcl-2 and p53 staining 
results, which indicate an apoptotic process. 
To the best of our knowledge, 5 patients have been 
reported as having granular cell type ameloblastoma 
with metastasis [11-15]. The metastatic sites of these 
patients were bilateral in the lungs in 2 cases, the ver-
tebrae in 2 cases, and a lymph node in one case. The 
intracranial metastasis of granular cell type amelo-
blastoma was not reported before. Except for the pa-
tient with cervical lymph node metastasis (diagnosed 
concurrent with the primary tumor), the average in-
terval between diagnosis of the primary tumor and 
diagnosis of metastasis was 33 years (range, 18 - 45 
years). 
 
Intracranial Involvement 
Intracranial involvement presented in 6.4-9.0% of 
cases involving metastasis [5], and a total of 12 patients 
with intracranial extension or brain metastasis have 
been reported since 1966 [7,16-25]. Seven of these 
patients had intracranial extension due to direct inva-
sion of the tumor, and three patients showed distant 
brain metastasis. The pattern of intracranial involve-
ment in the other 2 patients was not identified. Our 
patient is the first case reported with intracranial peri-
neural tumor spread. 
 
Perineural Tumor Spread 
Perineural involvement is a well-recognized presen-
tation in head and neck cancers, and the incidence of 
perineural involvement varies with histopathology. In 
ameloblastoma, a total of 11 patients have been re-
ported with “local” perineural infiltration of the infe-
rior alveolar nerve in mandibular ameloblastomas, 
mainly in the solid type with follicular pattern. Ap-
proximately 40% of patients with perineural spread are 
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asymptomatic [25], and the symptomatic spread usu-
ally first presents with sensory change, followed by 
motor weakness if the spread is extensive.  
Perineural spread is a type of perineural involve-
ment which describes the spread of gross tumor along 
the space surrounding a nerve. The pattern of peri-
neural spread is typically in a retrograde fashion toward 
the brainstem, but both antegrade and retrograde spread 
can occur. Perineural spread can involve different 
nerves once the tumor reaches a junction or spreads 
close to another nerve [26]. The pathogenesis of peri-
neural spread is unclear. However, increased expres-
sion of neural growth factor (NGF), p75 neurotrophin 
receptor (NTR), and neural cell adhesion molecule 
(NCAM) have been reported in head and neck tumors 
with perineural involvement, and may contribute to its 
pathogenesis [27-29]. 
MRI findings associated with perineural spread 
include nerve enlargement and nerve enhancement on 
fat-suppressed T1-weighted images. Although peri-
neural spread is usually continuous pathologically, the 
image may show a “skip lesion” due to low tumor 
burden in an abnormal area. The low rate of accuracy 
of MRI (63%) for predicting entire nerve involvement 
may explain why such involvement is underestimated 
clinically. The nerves most commonly involved in head 
and neck tumors are the maxillary branch, mandibular 
branch of the trigeminal nerve, and the facial nerve. 
The abducens nerve may be affected when the cav-
ernous sinus is involved [30]. 
According to the above theories, the perineural 
tumor spread in our patient may have been initially 
caused by perineural involvement of the left inferior 
alveolar nerve in a retrograde fashion. When the tumor 
reached the cavernous sinus, the left abducens nerve 
was involved, with further retrograde spreading. The 
discontinuity between the primary recurrent tumor and 
the Meckel’s cave lesion may be referred to as a “skip 
lesion” that was mentioned earlier. However, hema-
togenous cavernous sinus metastasis with secondary 
perineural spread along the sixth cranial nerve may also 
be a possible mechanism of tumor spread. 
 
Treatment 
Development of a standard protocol for treatment 
of metastasizing ameloblastoma is limited by the lack 
of experience with these rare tumors. The mainstay 
treatment is currently believed to be complete resection 
of the primary tumor; when metastatic disease is dis-
covered, whenever possible, treatment should include 
surgical management [31]. Although the use of chem-
otherapy has been mentioned, its overall effect is not 
clear [32], and a patient’s response to radiotherapy is 
unpredictable [33]. Due to inconclusive evidence of 
their benefits, chemotherapy and radiotherapy should 
be reserved for inoperable patients. 
 
CONCLUSIONS 
An extraordinary case of metastasizing granular 
cell type ameloblastoma is described in which intra-
cranial perineural spread via the sixth cranial nerve was 
confirmed by histological examination. Inadequate 
surgical excision of the primary lesion plays an im-
portant role in recurrent ameloblastomas, and the risk 
for metastasis of ameloblastomas is related to multiple 
recurrences and surgeries. A lack of malignant trans-
formation may be associated with slow tumor growth at 
the metastatic site. Due to the scarcity of cases, we can 
understand the implications of granular cell change and 
the pathogenesis of metastasis only through continued 
reporting of such rare cases. Current treatment con-
cepts for metastasizing ameloblastomas include close 
follow-up, or resection when possible. Evidence of the 
efficacy of chemotherapy and radiotherapy for treating 
metastasizing ameloblastoma remains inconclusive. 
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